Biological therapy in the treatment of melanoma

Authors

Simona Roxana Georgescu, Carol Davila University of Medicine and Pharmacy, Department of Dermatology and Venereology, Bucharest, RomaniaFollow
Mihaela Roxana Ioghen, Victor Babes Hospital for Infectious and Tropical Diseases, Department of Dermatology, Bucharest, RomaniaFollow
Maria Isabela Sarbu, Carol Davila University of Medicine and Pharmacy, Department of Dermatology and Venereology, Bucharest, RomaniaFollow
Alexandra-Florentina Ion, Victor Babes Hospital for Infectious and Tropical Diseases, Department of Dermatology, Bucharest, RomaniaFollow
Ela Ghita, Victor Babes Hospital for Infectious and Tropical Diseases, Department of Dermatology, Bucharest, RomaniaFollow
Cristina-Iulia Mitran, Victor Babes Hospital for Infectious and Tropical Diseases, Department of Dermatology, Bucharest, RomaniaFollow
Madalina-Irina Mitran, Victor Babes Hospital for Infectious and Tropical Diseases, Department of Dermatology, Bucharest, RomaniaFollow
Vasile Benea, Victor Babes Hospital for Infectious and Tropical Diseases, Department of Dermatology, Bucharest, RomaniaFollow
Mircea Tampa, Carol Davila University of Medicine and Pharmacy, Department of Dermatology and Venereology, Bucharest, RomaniaFollow

Abstract

Melanoma is one of the most aggressive tumors and its incidence is on the rise. The low rates of survival in metastatic melanoma has led to the development of new drugs for this type of patient, such as biological therapy which has shown remarkable results. This therapy is based on stimulation of the immune system to fight tumoral cells through: injection of cytokines with immunomodulatory properties (interleukin-2, alpha-interferon), vaccination with tumor antigens or immune cells that process tumor antigens, adoptive immunotherapy, inhibition of immune checkpoints (PD-1, CTLA-4), inhibition or stimulation of immune modulator molecules (OX-40, LAG-3), inhibition of signaling pathways involved in cell proliferation (Raf/MAPK/ERK signaling pathway), or administration of oncolytic viruses. Biological therapy in melanoma has shown promise in laboratory and clinical studies, with more therapeutic targets to be revealed as new molecular and cellular mechanisms of the disease are discovered.

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Recommended Citation

Georgescu, Simona Roxana; Ioghen, Mihaela Roxana; Sarbu, Maria Isabela; Ion, Alexandra-Florentina; Ghita, Ela; Mitran, Cristina-Iulia; Mitran, Madalina-Irina; Benea, Vasile; and Tampa, Mircea (2018) "Biological therapy in the treatment of melanoma," Journal of Mind and Medical Sciences: Vol. 5: Iss. 2, Article 5.
DOI: https://doi.org/10.22543/7674.52.P169175
Available at: https://scholar.valpo.edu/jmms/vol5/iss2/5